Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: BMS, uniQure gene therapy deal advances

    Bristol-Myers Squibb Co. (NYSE:BMY) selected three undisclosed targets under its gene therapy collaboration with uniQure N.V. (NASDAQ:QURE), triggering a $15 million payment to uniQure. The collaboration, announced in …

    Published on 8/10/2015
  • FINANCIAL NEWS: Turing raises $90M, buys U.S. rights to Daraprim

    Turing Pharmaceuticals AG (New York, N.Y.) raised $90 million in a series A round led by Martin Shkreli, the company's founder and CEO. Undisclosed institutional investors also participated. Turing also said it issued …

    Published on 8/10/2015
  • FINANCIAL NEWS: Biotechs end bleak week with late rally

    Biotech indices rallied late Friday after sinking earlier in the day, but still lost ground during the week. The BioCentury 100 shed 87.07 to 7,475.14 on Friday, while the NASDAQ Biotechnology Index (NBI) lost 27.29 to …

    Published on 8/7/2015
  • FINANCIAL NEWS: Santhera raises CHF27.7M

    Santhera Pharmaceuticals Holding AG (SIX:SANN) raised CHF27.7 million ($28.6 million) through the sale of 300,000 shares at an average price of CHF92.38 in a follow-on conducted from Aug. 3-6. Kepler Chevreux was …

    Published on 8/7/2015
  • FINANCIAL NEWS: Aimmune raises $160M in bumped-up IPO

    Aimmune Therapeutics Inc. (NASDAQ:AIMT) gained $8.10 (51%) to $24.10 in its first day of trading Thursday after it raised $160 million through the sale of 10 million shares at $16 in an IPO underwritten by BofA Merrill …

    Published on 8/6/2015
  • FINANCIAL NEWS: Antiva raises $16M in series B

    Antiva Biosciences Inc. (Menlo Park, Calif.) raised $16 million in a series B round co-led by new investors Canaan Partners and Sofinnova Ventures. Undisclosed existing investors also participated. The proceeds will be …

    Published on 8/6/2015
  • FINANCIAL NEWS: Biotech stocks off on Thursday

    Biotech indices dipped Thursday, as the BioCentury 100 lost 351.02 (4%) to 7562.21, while the NASDAQ Biotechnology Index shed 159.73 (4%) to 3887.75. The NASDAQ was off 83.50 (2%) to 5,056.44, while the Dow Jones …

    Published on 8/6/2015
  • FINANCIAL NEWS: Cold Genesys raises $10M in series B

    Cold Genesys Inc. (Santa Ana, Calif.) raised $10 million in a series B round co-led by existing investor Ally Bridge Group and new investor WI Harper Group. New investors Whitesun Healthcare Ventures and Song Hong Fang …

    Published on 8/6/2015
  • FINANCIAL NEWS: Zynerba gains after $42M IPO

    Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) jumped $2.25 (16%) to $16.25 in its first day of trading Wednesday after raising $42 million through the sale of 3 million shares at $14 in an IPO underwritten by Jefferies; …

    Published on 8/5/2015
  • FINANCIAL NEWS: Financial tracks

    The Rodman & Renshaw unit of H.C. Wainwright & Co. hired Raghuram Selvaraju as managing director in equity research. Selvaraju was a senior biotechnology analyst at MLV.

    Published on 8/4/2015
  • FINANCIAL NEWS: Intec raises $30.2M in U.S. listing

    Intec Pharma Ltd. (Tel Aviv:INTP; NASDAQ:NTEC) held at $6 in its first day of trading on NASDAQ after it raised $30.2 million through the sale of 5 million shares at $6 in a U.S. listing underwritten by Maxim Group and …

    Published on 8/4/2015
  • FINANCIAL NEWS: AMAG raises $200.8M in follow-on

    AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) raised $200.8 million through the sale of 3.1 million shares at $63.75 in a follow-on underwritten by Jefferies; Barclays; Leerink; Guggenheim; and Raymond James. The specialty …

    Published on 7/31/2015
  • FINANCIAL NEWS: Genocea raises $50.1M in follow-on

    Genocea Biosciences Inc. (NASDAQ:GNCA) raised $50.1 million through the sale of 3.9 million shares at $13 in a follow-on underwritten by Cowen; Piper Jaffray; Stifel; and Needham. Genocea proposed the offering after …

    Published on 7/30/2015
  • FINANCIAL NEWS: vTv falls after $117.2M IPO

    vTv Therapeutics Inc. (NASDAQ:VTVT) lost $4.17 (28%) to $10.83 in its first day of trading Thursday after raising $117.2 million through the sale of 7.8 million shares at $15 in an IPO underwritten by Piper Jaffray; …

    Published on 7/30/2015
  • FINANCIAL NEWS: Zogenix raises $85.5M in follow-on

    Zogenix Inc. (NASDAQ:ZGNX) raised $85.5 million through the sale of 4.8 million shares at $18 in a follow-on underwritten by Leerink; Stifel; Oppenheimer; and Brean Capital. The company proposed the offering after …

    Published on 7/30/2015
  • FINANCIAL NEWS: Ariad, PDL in Iclusig royalty deal

    Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) will receive $100 million from PDL BioPharma Inc. (NASDAQ:PDLI) in exchange for royalties on future sales of Iclusig ponatinib. The drug is approved in the U.S. and EU to treat …

    Published on 7/29/2015
  • FINANCIAL NEWS: Foresite closes $450M fund

    Foresite Capital Management closed Foresite Capital Fund III with $450 million. Managing director Christine Aylward said the firm will make investments of up to $100 million in public and private late-stage U.S. …

    Published on 7/29/2015
  • FINANCIAL NEWS: Deerfield launches $550M VC fund

    Deerfield Management closed a $550 million healthcare venture capital fund, which it said it will invest in early stage science and therapeutics to treat genetic diseases, cancer and Orphan diseases. The firm said the …

    Published on 7/28/2015
  • FINANCIAL NEWS: NantKwest gains in trading debut

    NantKwest Inc. (NASDAQ:NK) gained $9.64 (39%) to $34.94 in its first day of trading Tuesday after raising $207.2 million in a bumped up IPO of 8.3 million shares at $25 that valued the company at $2 billion, based on 78…

    Published on 7/28/2015
  • FINANCIAL NEWS: Ally Bridge launches healthcare hedge fund

    Ally Bridge Group launched ABG-LB, a hedge fund of undisclosed size that will invest primarily in healthcare companies headquartered in Greater China that are listed in China or the U.S.Chief Investment Officer Bin Li …

    Published on 7/27/2015
  • FINANCIAL NEWS: Biosimilar play Oncobiologics raises $31M

    Oncobiologics Inc. (Cranbury, N.J.) raised $31 million in a venture round led by Perceptive Advisors. New investors Cormorant Global Healthcare Master Fund; Longwood Capital Partners; and venBio Select Fund also …

    Published on 7/27/2015
  • FINANCIAL NEWS: Financial tracks

    Evercore (NYSE:EVR) hired Edmund Baxter as a senior managing director in its healthcare group. He was a senior managing director and head of west coast life sciences coverage at Bank of America Merrill Lynch.

    Published on 7/27/2015
  • FINANCIAL NEWS: Index raises EUR 60M toward life sciences fund

    Index Ventures has raised EUR 60 million ($66.5 million) toward Index Ventures Life VII, a new fund with an indefinite target size, according to an SEC filing. The firm did not respond to inquiries.In March 2012, the …

    Published on 7/27/2015
  • FINANCIAL NEWS: leon-nanodrugs raises EUR 18.5M in series A

    leon-nanodrugs GmbH (Munich, Germany) raised EUR 18.5 million ($20.5 million) in the first close of a planned EUR 21.5 million ($23.8 million) series A round led by new investor TVM Capital Life Science. New investors …

    Published on 7/27/2015
  • FINANCIAL NEWS: Exelixis raises $135M in follow-on

    Exelixis Inc. raised $135 million through the sale of 25 million shares at $5.40 in a follow-on underwritten by Cowen; William Blair; and Stifel. The company proposed to sell 20 million shares after market on Tuesday, …

    Published on 7/24/2015

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993